{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:53:41Z","timestamp":1777463621588,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Pain"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Long-term opioid analgesic prescribing in chronic non-cancer pain (CNCP) is a growing worldwide concern. This has implications for optimal healthcare management in general and chronic pain management specifically. This work documents the development of a review tool and its use in the South West of England in a locality that showed opioid prescribing levels higher than surrounding localities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An electronic tool which enabled calculation of total prescribed morphine-equivalent doses was developed to allow general practitioners (GPs) to undertake reviews of CNCP patients. This tool was used to assess strong opioid prescribing over a 3-month period at every GP practice (n\u2009=\u200941) in the locality. Every prescription for morphine, oxycodone, pethidine and fentanyl during this period was included. Aspects assessed included drug(s) prescribed, dose prescribed, whether tramadol was prescribed concurrently, whether the drugs were potentially being overused and\/or whether the patient was in palliative care. Patients prescribed over 120\u2009mg morphine equivalent per day were reviewed in greater depth, as this is an indication for specialist input.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 1881 patients received a prescription in the assessment period. Morphine was the most commonly prescribed drug (n\u2009=\u2009847). In all, 363 CNCP patients were prescribed a dose equal to or above 120\u2009mg morphine a day, with a maximum morphine-equivalent dose of 890\u2009mg being prescribed. Over 11% (n\u2009=\u2009211) of patients were concurrently prescribed tramadol. The most frequently cited reason for prescription of high-dose opioids was found to be a musculoskeletal pain of the back, neck, joints or limbs. The care of 85 specific CNCP patients was reviewed and optimised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>No published work to date has documented such an in-depth analysis of primary-care opioid analgesic prescribing utilising prescriber data. Assessing total-dose morphine-equivalent prescribing using this method provides valuable insights into the potential need for urgent medication review. The tool developed may be of value to other GP practices following validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2049463717742420","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T09:16:54Z","timestamp":1510737414000},"page":"171-182","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Opioid prescribing in general practice: use of a two-stage review tool to identify and assess high-dose prescribing"],"prefix":"10.1177","volume":"12","author":[{"given":"Rhys","family":"Ponton","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sawyer","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"bibr1-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.520"},{"key":"bibr2-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2014.496.x"},{"key":"bibr3-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"bibr4-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1833"},{"key":"bibr5-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.09.017"},{"key":"bibr6-2049463717742420","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2012\/15\/ES9"},{"key":"bibr7-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.8165"},{"key":"bibr8-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011512"},{"key":"bibr9-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1177\/2049463712439131"},{"key":"bibr10-2049463717742420","volume-title":"Opioids for persistent pain: good practice","author":"The British Pain Society","year":"2010"},{"key":"bibr11-2049463717742420","unstructured":"The Royal College of Anaesthetists. Opioids aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain. London: The Royal College of Anaesthetists, http:\/\/www.rcoa.ac.uk\/faculty-of-pain-medicine\/opioids-aware (2015, accessed 9 November 2017)."},{"key":"bibr12-2049463717742420","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2559"},{"key":"bibr13-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006605.pub2"},{"key":"bibr14-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000000249"},{"key":"bibr15-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004959.pub4"},{"key":"bibr16-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3182863447"},{"key":"bibr17-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.05.031"},{"issue":"2","key":"bibr18-2049463717742420","volume":"4","author":"Huber E","year":"2016","journal-title":"Healthcare (Basel)"},{"key":"bibr19-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6380"},{"key":"bibr20-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.002"},{"key":"bibr21-2049463717742420","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-5-201109060-00011"},{"key":"bibr22-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00483-8"},{"issue":"02","key":"bibr23-2049463717742420","first-page":"146","volume":"9","author":"McCracken LM","year":"2008","journal-title":"Prim Health Care Res"},{"key":"bibr24-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1177\/2049463715579284"},{"key":"bibr25-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1177\/2049463715574111"},{"key":"bibr26-2049463717742420","unstructured":"Public Health England (PHE). Plymouth Unitary Authority health profile 2014, http:\/\/www.apho.org.uk\/resource\/item.aspx?RID=142335 (2014, accessed 9 November 2017)."},{"key":"bibr27-2049463717742420","unstructured":"Home Office, UK, Controlled drugs regulations (Misuse of Drugs Regulations). Report, December 2001."},{"key":"bibr28-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.05.017"},{"key":"bibr29-2049463717742420","unstructured":"Washington State Agency Medical Directors\u2019 Group (AMDG). Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. Washington, DC: AMDG, 2010, http:\/\/www.agencymeddirectors.wa.gov\/files\/opioidgdline.pdf (accessed 9 November 2017)."},{"key":"bibr30-2049463717742420","volume-title":"Summary of product characteristics \u2013 Zydol capsules","author":"Gr\u00fcnenthal Ltd","year":"2015"},{"key":"bibr31-2049463717742420","volume-title":"What are the equivalent doses of oral morphine to other oral opioids when used as analgesics in adult palliative care?","author":"UK Medicines Information (UKMi)","year":"2011"},{"key":"bibr32-2049463717742420","unstructured":"Home Office, UK, The Misuse of Drugs Misuse of Drugs (Safe Custody) (Amendment) (England, Wales Scotland) Regulations, 2014."},{"key":"bibr33-2049463717742420","author":"Selby and York Palliative Care Team and Pharmacy Group. York Hospitals NHS Foundation Trust and NHS North Yorkshire and York","year":"2009","journal-title":"Palliative care analgesic dose conversion"},{"key":"bibr34-2049463717742420","unstructured":"McAuley D. GlobalRPh \u2013 opioid analgesic converter, http:\/\/globalrph.com\/narcoticonv.htm (2012, accessed 9 December 2016)."},{"key":"bibr35-2049463717742420","unstructured":"NHS South Region. Controlled drug newsletter, https:\/\/www.england.nhs.uk\/south\/wp-content\/uploads\/sites\/6\/2016\/07\/nhs-cd-newsletter-july16.pdf (2016, accessed 31 August 2016)."},{"key":"bibr36-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12821"},{"key":"bibr37-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.12.007"},{"key":"bibr38-2049463717742420","volume-title":"Room for review. A guide to medication review: the agenda for patients, practitioners and managers","author":"Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme","year":"2002"},{"key":"bibr39-2049463717742420","volume-title":"A guide to medication review","author":"Clyne WBA","year":"2008"},{"key":"bibr40-2049463717742420","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X675403"},{"key":"bibr41-2049463717742420","unstructured":"Home Office. Learning from tragedy, keeping patients safe. Overview of the Government\u2019s action programme in response to the recommendations of the Shipman Inquiry. London: The Stationery Office, 2007, https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/228886\/7014.pdf (accessed 9 November 2017)."},{"key":"bibr42-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200201000-00010"},{"key":"bibr43-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3533"},{"key":"bibr44-2049463717742420","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31816b2f26"},{"key":"bibr45-2049463717742420","volume-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"Department of Health","year":"2007"},{"key":"bibr46-2049463717742420","unstructured":"Home Office, UK, The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014, Sess. (2014)."}],"container-title":["British Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2049463717742420","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2049463717742420","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2049463717742420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:21:04Z","timestamp":1777382464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2049463717742420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1177\/2049463717742420"],"URL":"https:\/\/doi.org\/10.1177\/2049463717742420","relation":{},"ISSN":["2049-4637","2049-4645"],"issn-type":[{"value":"2049-4637","type":"print"},{"value":"2049-4645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]}}}